Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer anorexia and cachexia.

M J Tisdale1

  • 1Pharmaceutical Sciences Research Institute, Aston University, Birmingham, United Kingdom.

Nutrition (Burbank, Los Angeles County, Calif.)
|May 30, 2001
PubMed
Summary

Cancer cachexia causes significant muscle and fat loss, distinct from anorexia. Tumor-derived factors, not just appetite loss, drive this wasting, suggesting new therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Green Tea Polyphenol Epigallocatechin-3-Gallate (EGCg) Attenuates Skeletal Muscle Atrophy in a Rat Model of Sarcopenia.

The Journal of frailty & aging·2016
Same author

Functional identity of receptors for proteolysis-inducing factor on human and murine skeletal muscle.

British journal of cancer·2014
Same author

Role of Ca2+ in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle.

Cellular signalling·2012
Same author

Attenuation of muscle atrophy by an N-terminal peptide of the receptor for proteolysis-inducing factor (PIF).

British journal of cancer·2011
Same author

Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat.

International journal of obesity (2005)·2010
Same author

Studies on the antiobesity effect of zinc-α2-glycoprotein in the ob/ob mouse.

International journal of obesity (2005)·2010

Area of Science:

  • Oncology
  • Metabolism
  • Biochemistry

Background:

  • Cancer cachexia is characterized by severe loss of adipose and lean body mass.
  • Anorexia alone does not fully explain cachexia's tissue depletion.
  • Nutritional support and appetite stimulants are ineffective in restoring lean body mass.

Purpose of the Study:

  • To differentiate cachexia from anorexia and identify key mechanisms of tissue wasting.
  • To investigate the role of tumor products in driving cancer cachexia.
  • To explore potential therapeutic strategies targeting tumor-derived catabolic factors.

Main Methods:

  • Analysis of physiological differences between cachexia and anorexia.
  • Identification of tumor-secreted factors contributing to cachexia.
  • Investigation of molecular pathways involved in skeletal muscle catabolism (ubiquitin-proteasome system).

Main Results:

  • Cachexia involves significant skeletal muscle loss, unlike anorexia.
  • Tumor products, including a lipid-mobilizing factor and a proteolysis-inducing factor, are implicated in cachexia.
  • Eicosapentaenoic acid can attenuate the effects of proteolysis-inducing factors.

Conclusions:

  • Cancer cachexia is driven by specific tumor-derived catabolic factors.
  • Targeting these tumor factors offers a promising therapeutic avenue for managing cancer cachexia.
  • Further research into antagonists of these factors is warranted for novel treatment development.

Related Experiment Videos